The expression of DUSP1 gene is induced in human skin fibroblasts by oxidative/heat stress and growth factors. It specifies a protein with structural features similar to members of the non-receptor-type protein-tyrosine phosphatase family, and which has significant amino-acid sequence similarity to a Tyr/Ser-protein phosphatase encoded by the late gene H1 of vaccinia virus. The bacterially expressed and purified DUSP1 protein has intrinsic phosphatase activity, and specifically inactivates mitogen-activated protein (MAP) kinase in vitro by the concomitant dephosphorylation of both its phosphothreonine and phosphotyrosine residues. Furthermore, it suppresses the activation of MAP kinase by oncogenic ras in extracts of Xenopus oocytes. Thus, DUSP1 may play an important role in the human cellular response to environmental stress as well as in the negative regulation of cellular proliferation.
^Tanoue T, Yamamoto T, Maeda R, Nishida E (Jul 2001). "A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs". The Journal of Biological Chemistry276 (28): 26629–39. doi:10.1074/jbc.M101981200. PMID11359773.
^ abcSlack D, Seternes O, Gabrielsen M, Keyse S (May 2001). "Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1". The Journal of Biological Chemistry276 (19): 16491–500. doi:10.1074/jbc.M010966200. PMID11278799.
^Calvisi D, Pinna F, Meloni F, Ladu S, Pellegrino R, Sini M et al. (Jun 2008). "Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma". Cancer Research68 (11): 4192–200. doi:10.1158/0008-5472.CAN-07-6157. PMID18519678.
Martell K, Angelotti T, Ullrich A (Feb 1998). "The "VH1-like" dual-specificity protein tyrosine phosphatases". Molecules and Cells8 (1): 2–11. PMID9571625.
Keyse S (Apr 1998). "Protein phosphatases and the regulation of MAP kinase activity". Seminars in Cell & Developmental Biology9 (2): 143–52. doi:10.1006/scdb.1997.0219. PMID9599409.
Abraham S, Clark A (Dec 2006). "Dual-specificity phosphatase 1: a critical regulator of innate immune responses". Biochemical Society Transactions34 (Pt 6): 1018–23. doi:10.1042/BST0341018. PMID17073741.
Raingeaud J, Gupta S, Rogers J, Dickens M, Han J, Ulevitch R et al. (Mar 1995). "Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine". The Journal of Biological Chemistry270 (13): 7420–6. doi:10.1074/jbc.270.13.7420. PMID7535770.
Kwak S, Hakes D, Martell K, Dixon J (Feb 1994). "Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene". The Journal of Biological Chemistry269 (5): 3596–604. PMID8106404.
Emslie E, Jones T, Sheer D, Keyse S (May 1994). "The CL100 gene, which encodes a dual specificity (Tyr/Thr) MAP kinase phosphatase, is highly conserved and maps to human chromosome 5q34". Human Genetics93 (5): 513–6. doi:10.1007/BF00202814. PMID8168826.
Sun H, Charles C, Lau L, Tonks N (Nov 1993). "MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo". Cell75 (3): 487–93. doi:10.1016/0092-8674(93)90383-2. PMID8221888.
Alessi D, Smythe C, Keyse S (Jul 1993). "The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts". Oncogene8 (7): 2015–20. PMID8390041.
Brondello J, Pouysségur J, McKenzie F (Dec 1999). "Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation". Science (New York, N.Y.)286 (5449): 2514–7. doi:10.1126/science.286.5449.2514. PMID10617468.
Slack D, Seternes O, Gabrielsen M, Keyse S (May 2001). "Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1". The Journal of Biological Chemistry276 (19): 16491–500. doi:10.1074/jbc.M010966200. PMID11278799.
Manzano R, Montuenga L, Dayton M, Dent P, Kinoshita I, Vicent S et al. (Jun 2002). "CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential". Oncogene21 (28): 4435–47. doi:10.1038/sj.onc.1205542. PMID12080474.
Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato A, Akira S et al. (Dec 2002). "Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2". The Journal of Biological Chemistry277 (49): 47444–50. doi:10.1074/jbc.M208140200. PMID12356755.
Denkert C, Schmitt W, Berger S, Reles A, Pest S, Siegert A et al. (Dec 2002). "Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma". International Journal of Cancer. Journal International Du Cancer102 (5): 507–13. doi:10.1002/ijc.10746. PMID12432554.